JD Health International Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Enlin Jin
Chief executive officer
CN¥8.4m
Total compensation
| CEO salary percentage | 15.0% |
| CEO tenure | 3.3yrs |
| CEO ownership | 0.01% |
| Management average tenure | no data |
| Board average tenure | 4.1yrs |
Recent management updates
Recent updates
JD Health International's (HKG:6618) Returns On Capital Not Reflecting Well On The Business
Dec 17
Investors Appear Satisfied With JD Health International Inc.'s (HKG:6618) Prospects
Nov 04Is Now An Opportune Moment To Examine JD Health International Inc. (HKG:6618)?
Sep 26A Look At The Fair Value Of JD Health International Inc. (HKG:6618)
Sep 05Results: JD Health International Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts
Aug 19The Returns On Capital At JD Health International (HKG:6618) Don't Inspire Confidence
Aug 08Why We're Not Concerned About JD Health International Inc.'s (HKG:6618) Share Price
Jul 21This Is Why JD Health International Inc.'s (HKG:6618) CEO Compensation Looks Appropriate
Jun 14Calculating The Intrinsic Value Of JD Health International Inc. (HKG:6618)
May 21JD Health International Inc.'s (HKG:6618) Stock Retreats 30% But Earnings Haven't Escaped The Attention Of Investors
Apr 17JD Health International (HKG:6618) Is Reinvesting At Lower Rates Of Return
Apr 08At HK$29.80, Is It Time To Put JD Health International Inc. (HKG:6618) On Your Watch List?
Mar 01Revenues Tell The Story For JD Health International Inc. (HKG:6618)
Jan 16CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | CN¥3b |
| Mar 31 2024 | n/a | n/a | CN¥2b |
| Dec 31 2023 | CN¥8m | CN¥1m | CN¥2b |
| Sep 30 2023 | n/a | n/a | CN¥2b |
| Jun 30 2023 | n/a | n/a | CN¥2b |
| Mar 31 2023 | n/a | n/a | CN¥1b |
| Dec 31 2022 | CN¥8m | CN¥1m | CN¥380m |
| Sep 30 2022 | n/a | n/a | -CN¥7m |
| Jun 30 2022 | n/a | n/a | -CN¥395m |
| Mar 31 2022 | n/a | n/a | -CN¥734m |
| Dec 31 2021 | CN¥3m | CN¥301k | -CN¥1b |
Compensation vs Market: Enlin's total compensation ($USD1.15M) is above average for companies of similar size in the Hong Kong market ($USD827.01K).
Compensation vs Earnings: Enlin's compensation has been consistent with company performance over the past year.
CEO
Enlin Jin (43 yo)
3.3yrs
Tenure
CN¥8,385,000
Compensation
Mr. Enlin Jin is Chief Executive Officer & Executive Director of JD Health International Inc. from September 06, 2021. Mr. Jin has extensive experience in pharmaceuticals and TMT industry. He serves as the...
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Executive Director | 3.3yrs | CN¥8.39m | 0.0095% HK$ 8.9m | |
| Independent Non-Executive Director | 2.7yrs | CN¥818.00k | 0.00030% HK$ 281.2k | |
| Chairman | 4.3yrs | CN¥407.82m | 0.55% HK$ 519.2m | |
| Non-Executive Director | 4.3yrs | no data | no data | |
| Independent Non-Executive Director | 4.1yrs | CN¥476.00k | 0.00040% HK$ 374.9k | |
| Independent Non-Executive Director | 4.1yrs | CN¥476.00k | 0.00040% HK$ 374.9k | |
| Independent Non-Executive Director | 3.8yrs | CN¥463.00k | 0.00019% HK$ 178.1k |
4.1yrs
Average Tenure
51yo
Average Age
Experienced Board: 6618's board of directors are considered experienced (4.1 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/24 07:48 |
| End of Day Share Price | 2024/12/24 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
JD Health International Inc. is covered by 32 analysts. 18 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Yiqun Chen | BOCI Research Ltd. |
| Xiaomeng Zhuang | BofA Global Research |
| Shun Kei Law | CCB International Securities Limited |